Impact of CYP2C19 metaboliser status on SSRI response: a retrospective study of 9500 participants of the Australian Genetics of Depression Study

BACKGROUND: Variation within the CYP2C19 gene has been linked to differential metabolism of selective serotonin reuptake inhibitors (SSRIs). Pharmacogenetic recommendations based on the effect of CYP2C19 variants have been made available and are used increasingly by clinical practitioners. Nonethele...

Descripción completa

Detalles Bibliográficos
Autores principales: Campos, Adrian I., Byrne, Enda M., Mitchell, Brittany L., Wray, Naomi R., Lind, Penelope A., Licinio, Julio, Medland, Sarah E., Martin, Nicholas G., Hickie, Ian B., Rentería, Miguel E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8975743/
https://www.ncbi.nlm.nih.gov/pubmed/35094016
http://dx.doi.org/10.1038/s41397-022-00267-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8975743/
https://www.ncbi.nlm.nih.gov/pubmed/35094016
http://dx.doi.org/10.1038/s41397-022-00267-7

Ejemplares similares